Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer

NCT02459652 is registered in ClinicalTrials.gov with Japan Adjuvant Study Group of Pancreatic Cancer as lead sponsor.

NCT NCT02459652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02459652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer
Lead sponsor
Japan Adjuvant Study Group of Pancreatic Cancer
Phase
Phase 2
Overall status
Completed
Start date
December 28, 2012
Completion date
July 17, 2018
Enrollment
57 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer